Compare MAGN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAGN | EBS |
|---|---|---|
| Founded | 1864 | 1998 |
| Country | United States | United States |
| Employees | 8500 | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.2M | 423.6M |
| IPO Year | N/A | 2006 |
| Metric | MAGN | EBS |
|---|---|---|
| Price | $12.63 | $8.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | $12.00 |
| AVG Volume (30 Days) | 308.5K | ★ 743.9K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | $5.37 | $1.29 |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | ★ N/A | $119.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.82 | $5.62 |
| 52 Week High | $15.52 | $14.06 |
| Indicator | MAGN | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 69.80 | 49.58 |
| Support Level | $9.73 | $7.76 |
| Resistance Level | $12.92 | $8.78 |
| Average True Range (ATR) | 0.45 | 0.46 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 90.79 | 44.29 |
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.